JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YMAB
4901
DELISTED
Y-mAbs Therapeutics
YMAB
| $160K | ﹤0.01% |
32,683
-1,296
| -4% | -$9.41K |
2018 Q3
17 quarters
|
|
4902
Adicet Bio
ACET
$61.1M
| $159K | ﹤0.01% |
1,113
-34
| -3% | -$8.48K |
2021 Q2
6 quarters
|
|
4903
Alico
ALCO
$285M
| $159K | ﹤0.01% |
6,618
+3,193
| +93% | +$92.3K |
2022 Q2
2 quarters
|
|
4904
Blend Labs
BLND
$246M
| $159K | ﹤0.01% |
110,861
+9,764
| +10% | +$17.5K |
2021 Q3
5 quarters
|
|
4905
Woori Financial
WF
$18.6B
| $159K | ﹤0.01% |
5,773
+1,245
| +27% | +$33.2K |
2015 Q4
28 quarters
|
|
4906
Sprott Physical Gold and Silver Trust
CEF
$7.32B
| $158K | ﹤0.01% |
8,798
| – | – |
2018 Q1
19 quarters
|
|
4907
iShares Dow Jones US ETF
IYY
$3.1B
| $158K | ﹤0.01% |
1,689
-200
| -11% | -$18.8K |
2013 Q2
38 quarters
|
|
4908
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.8B
| $158K | ﹤0.01% |
+2,016
| New | +$161K |
2022 Q4
0 quarters
|
|
|
PETQ
4909
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $158K | ﹤0.01% |
17,152
-378
| -2% | -$3.53K |
2017 Q4
20 quarters
|
|
4910
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.14B
| $157K | ﹤0.01% |
1,161
+1,160
| +116,000% | +$154K |
2022 Q2
2 quarters
|
|
4911
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$123M
| $157K | ﹤0.01% |
694
-18,725
| -96% | -$5.13M |
2021 Q2
6 quarters
|
|
4912
Franklin FTSE Japan ETF
FLJP
$4.24B
| $156K | ﹤0.01% |
6,504
-2,997,276
| -100% | -$69.8M |
2022 Q3
1 quarter
|
|
4913
Inspired Entertainment
INSE
$104M
| $156K | ﹤0.01% |
12,264
+566
| +5% | +$6.28K |
2019 Q2
14 quarters
|
|
|
PAMT
4914
PAMT Corp
PAMT
$245M
| $156K | ﹤0.01% |
6,017
+2,411
| +67% | +$68.7K |
2016 Q4
24 quarters
|
|
|
CPAC
4915
Cementos Pacasmayo
CPAC
$1.06B
| $155K | ﹤0.01% |
30,000
-1,025
| -3% | -$5.39K |
2018 Q3
17 quarters
|
|
4916
Red Violet
RDVT
$1.27B
| $155K | ﹤0.01% |
6,715
+460
| +7% | +$9.36K |
2021 Q4
4 quarters
|
|
|
SFIX
4917
Stitch Fix
SFIX
$359M
| $155K | ﹤0.01% |
50,127
-22,202
| -31% | -$83K |
2018 Q2
18 quarters
|
|
4918
Direxion Daily TSLA Bull 2X ETF
TSLL
$4.33B
| $155K | ﹤0.01% |
24,760
-18
| -0.1% | -$229 |
2022 Q3
1 quarter
|
|
|
JBIO
4919
Jade Biosciences
JBIO
$877M
| $154K | ﹤0.01% |
150
-45
| -23% | -$32.7K |
2021 Q3
5 quarters
|
|
4920
Criteo S.A.
CRTO
$717M
| $154K | ﹤0.01% |
5,911
+506
| +9% | +$13.1K |
2014 Q2
34 quarters
|
|
4921
PUT
Rivian
RIVN
$21.2B
| $153K | ﹤0.01% |
8,300
-59,100
| -88% | -$1.74M |
2021 Q4
4 quarters
|
|
|
EQIN
4922
Columbia U.S. Equity Income ETF
EQIN
$306M
| $153K | ﹤0.01% |
+4,080
| New | +$149K |
2022 Q4
0 quarters
|
|
|
RNLX
4923
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $153K | ﹤0.01% |
82,168
-3,905
| -5% | -$6.1K |
2021 Q1
7 quarters
|
|
4924
Aptus Collared Investment Opportunity ETF
ACIO
$2.44B
| $152K | ﹤0.01% |
+5,266
| New | +$154K |
2022 Q4
0 quarters
|
|
|
ETG
4925
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.76B
| $152K | ﹤0.01% |
+10,068
| New | +$157K |
2022 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.